Institute for Clinical Immunology and Transfusion Medicine, Justus Liebig University, Giessen, Germany.
Centre for Research and Development, Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand.
Transfusion. 2020 Apr;60(4):815-821. doi: 10.1111/trf.15707. Epub 2020 Feb 18.
Neutrophil specific Fcγ receptor IIIb (CD16b) is a low-affinity IgG receptor. Its polymorphic variants are associated with human neutrophil antigens (HNA). HNA-1a and HNA-1b differ in four amino acids. Immunization can lead to the production of alloantibodies. The exact contribution of four amino acid exchanges for the formation of HNA-1a, -1b epitopes is currently unknown.
Permutation of each polymorphic amino acid from wild-type CD16b cDNA constructs was performed and expressed on HEK293 cells. All 16 receptor variants were produced and tested against 19 well-characterized HNA antisera in an antigen capture assay.
Analyzing the reaction pattern revealed that anti-HNA-1a antibodies can bind whenever asparagine (N) is present in position 65, regardless of the three other positions (CD16b N). Anti-HNA-1b antibodies can bind when serine (S) is present in position 36 (CD16b S), when N is present in position 82 (CD16b *N), or both (CD16b S*N). CD16b variants with N65 and S36 and/or N82 (such as CD16b SNN*) bind both, anti-HNA-1a and anti-HNA-1b alloantibodies. If these specific amino acids are missing (as in CD16b RSD), no antibodies will bind.
Whereas the primary structure of HNA-1a and HNA-1b usually differs in four amino acids, epitope composition is not "antithetical". N65 alone determines the presence of HNA-1a, and S36 and/or N82 determine the presence of HNA-1b. Amino acid 106 does not participate in epitope formation. Our findings are of specific relevance when a HNA-1 phenotype is predicted from a genotype.
中性粒细胞特异性 Fcγ 受体 IIIb(CD16b)是一种低亲和力 IgG 受体。其多态变体与人类中性粒细胞抗原(HNA)有关。HNA-1a 和 HNA-1b 在四个氨基酸上存在差异。免疫接种可导致产生同种抗体。目前尚不清楚这四个氨基酸的变化对 HNA-1a、-1b 表位形成的确切贡献。
对野生型 CD16b cDNA 构建体中的每个多态性氨基酸进行置换,并在 HEK293 细胞上表达。产生了所有 16 种受体变体,并在抗原捕获测定中用 19 种经过充分表征的 HNA 抗血清进行了测试。
分析反应模式表明,抗 HNA-1a 抗体只要在位置 65 存在天冬酰胺(N),就可以结合,而不管其他三个位置(CD16bN)如何。抗 HNA-1b 抗体可以在位置 36 存在丝氨酸(S)时结合(CD16b S),在位置 82 存在 N 时结合(CD16b *N),或者两者都结合(CD16b S*N)。具有 N65 和 S36 和/或 N82 的 CD16b 变体(如 CD16b SNN*)结合抗 HNA-1a 和抗 HNA-1b 同种抗体。如果这些特定的氨基酸缺失(如 CD16b RSD),则没有抗体结合。
尽管 HNA-1a 和 HNA-1b 的一级结构通常在四个氨基酸上存在差异,但表位组成并非“对立”。N65 单独决定 HNA-1a 的存在,而 S36 和/或 N82 决定 HNA-1b 的存在。氨基酸 106 不参与表位形成。当从基因型预测 HNA-1 表型时,我们的发现具有特定的相关性。